Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-23-071506
Filing Date
2023-12-19
Accepted
2023-12-19 16:25:05
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-12-19

Document Format Files

Seq Description Document Type Size
1 ARS abio_ars_2023.pdf ARS 347385
  Complete submission text file 0000950170-23-071506.txt   479955
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-22873 | Film No.: 231497624
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)